Protagonist Therapeutics (PTGX) Insider Trading & Ownership $44.82 -0.69 (-1.51%) As of 01:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Protagonist Therapeutics (NASDAQ:PTGX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$16.18 M Get PTGX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protagonist Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PTGX Insider Buying and Selling by Quarter Protagonist Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/22/2025Asif AliCFOSell1,756$46.00$80,776.00 3/17/2025William D WaddillDirectorSell4,000$54.25$217,000.00 3/13/2025Arturo Md MolinaInsiderSell30,514$55.74$1,700,850.36 3/12/2025Asif AliCFOSell24,903$58.73$1,462,553.19 2/19/2025Dinesh V Ph D PatelCEOSell5,359$38.18$204,606.62 11/27/2024Arturo Md MolinaInsiderSell26,000$44.70$1,162,200.00 11/25/2024Dinesh V Ph D PatelCEOSell78,520$46.96$3,687,299.20 11/25/2024Suneel GuptaInsiderSell103,437$46.04$4,762,239.48 11/15/2024Arturo Md MolinaInsiderSell1,906$40.98$78,107.88 9/11/2024Asif AliCFOSell14,203$44.49$631,891.47 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/10/2024William D WaddillDirectorSell8,000$45.00$360,000.00 7/24/2024William D WaddillDirectorSell8,000$40.00$320,000.00 6/7/2024Dinesh V Ph D PatelCEOSell35,000$35.19$1,231,650.00 6/7/2024William D WaddillDirectorSell8,000$35.00$280,000.00 (Data available from 1/1/2013 forward) PTGX Insider Trading Activity - Frequently Asked Questions Who is on Protagonist Therapeutics's Insider Roster? The list of insiders at Protagonist Therapeutics includes Arturo Md Molina, Asif Ali, Dinesh V Ph D Patel, Suneel Gupta, and William D Waddill. Learn more on insiders at PTGX. What percentage of Protagonist Therapeutics stock is owned by insiders? 5.40% of Protagonist Therapeutics stock is owned by insiders. Learn more on PTGX's insider holdings. Which Protagonist Therapeutics insiders have been selling company stock? The following insiders have sold PTGX shares in the last 24 months: Arturo Md Molina ($2,941,158.24), Asif Ali ($2,665,561.92), Dinesh V Ph D Patel ($6,779,905.82), Suneel Gupta ($4,887,239.48), and William D Waddill ($1,583,636.50). How much insider selling is happening at Protagonist Therapeutics? Insiders have sold a total of 438,055 Protagonist Therapeutics shares in the last 24 months for a total of $18,857,501.96 sold. Protagonist Therapeutics Key ExecutivesDr. Dinesh V. Patel Ph.D. (Age 67)CEO, President, Secretary & Director Compensation: $1.03MMr. Asif Ali (Age 50)Executive VP & Chief Financial Officer Compensation: $631.04k2 recent tradesDr. Suneel K. Gupta Ph.D. (Age 66)Chief Development Officer Compensation: $719.21kDr. Mark Smythe Ph.D. (Age 59)Founder & VP Technology Mr. Mohammad Masjedizadeh Ph.D.Executive VP & Chief Technical OfficerMr. Matthew M. Gosling (Age 53)Executive VP & General Counsel Ms. Carena SpiveyHead of HR & Senior VP of Human ResourcesDr. Ashok Bhandari Ph.D. (Age 60)Executive VP & Chief Drug Discovery and Preclinical Development Officer Mr. Carter J. King (Age 53)Executive Vice President of Business Development Ms. Abha BommireddiExecutive Vice President of Portfolio & Program Management More Insider Trading Tools from MarketBeat Related Companies Moderna Insider Trades Viatris Insider Trades Roivant Sciences Insider Trades Revolution Medicines Insider Trades Lantheus Insider Trades BridgeBio Pharma Insider Trades TG Therapeutics Insider Trades Sarepta Therapeutics Insider Trades ADMA Biologics Insider Trades Blueprint Medicines Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:PTGX) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagonist Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagonist Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTGX Stock Free PTGX Stock Alerts